RE:RE:RE:RE:RE:Canaccord ups Price Target to $7I miss read that post his EPS as mentioned earlier is just hilarious, I would like to know were the NASH numbers are from, does he know whether there will be other drugs approved by then?
The true prevalence of the condition is still unknown due to lack of testing. If there are no competition and Tesamorelin will be the first approved drug the pricing of the drug will be much higher as well so there are many moving parts which each can effect the financial opportunity of an approved drug for NASH, also how can other drug companies been valued much higher based on their potential success and not THTX?
Pen injector yes innovative approach yes valued valued 30 percent compared to comps NO.